A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer
Primary: To compare the efficacy of TACE and TAIE.

Secondary: To compare the side effects of TACE and TAIE.

The outcome measurements include survival benefit and tumour regression induced by the two therapies.
Carcinoma, Hepatocellular
PROCEDURE: Transcatheter Arterial Chemoembolization (TACE)|PROCEDURE: Transcatheter Arterial Pegylated Interferon Embolization (TAIE)
regression of tumour size, assessment every 6 months
side effects, every treatment given every 8 - 12 weeks
Primary: To compare the efficacy of TACE and TAIE.

Secondary: To compare the side effects of TACE and TAIE.

The outcome measurements include survival benefit and tumour regression induced by the two therapies.